| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 01/25/2001 | CA2375954A1 Alpha-hydroxy-gamma-¬¬(carbocyclic-or heterocyclic-substituted)amino|carbonyl|alkanamide derivatives and uses thereof |
| 01/25/2001 | CA2375909A1 Tricyclic compounds bearing acyloxymethoxycarbonyl pendants |
| 01/25/2001 | CA2375467A1 Antisense therapy for hormone-regulated tumors |
| 01/25/2001 | CA2374052A1 Method for treating chronic pain using mek inhibitors |
| 01/25/2001 | CA2371328A1 Disinfecting composition based on h2o2, acids and metal ions |
| 01/24/2001 | EP1070755A1 Liquid mixture consisting of diesel gas oils and oxygenated compounds |
| 01/24/2001 | EP1070725A1 Solid dispersion containing sialic acid derivative |
| 01/24/2001 | EP1070716A1 Beta-carboline derivatives, process for their preparation and pharmaceutical compositions containing them |
| 01/24/2001 | EP1070714A1 Amidine compounds |
| 01/24/2001 | EP1070710A2 Dithiolan derivatives, their preparation and their therapeutic effect |
| 01/24/2001 | EP1070708A1 Triazole and imidazole derivatives |
| 01/24/2001 | EP1070707A1 1,4,5,6-tetrahydropyrimidine derivative as a vitronectin inhibitor |
| 01/24/2001 | EP1070704A1 VITAMIN D DERIVATIVES SUBSTITUTED AT THE 2$g(b)-POSITION |
| 01/24/2001 | EP1070703A1 Cyclobutene derivatives |
| 01/24/2001 | EP1070503A1 Compositions comprising very low molecular weight Heparin |
| 01/24/2001 | EP1070502A2 Compositions and methods for treating or preventing inflammatory diseases |
| 01/24/2001 | EP1070501A1 Method of preparing a dispersible fluoxetine tablet |
| 01/24/2001 | EP1070141A1 Immediate early genes and methods of use therefor |
| 01/24/2001 | EP1070084A1 PIPERAZINES AS INHIBITORS OF FRUCTOSE-1,6-BISPHOSPHATASE (FBPase) |
| 01/24/2001 | EP1070083A1 Crystalline forms of 1s- 1alpha (2s*,3r*), 9alpha]-6, 10-dioxo-n- (2-ethoxy-5 -oxo-tetrahydro-3 -furanyl) -9- (1-isoquinolyl) carbonyl]-amino] octahydro-6h -piridazino 1, 2-a] 1,2] diazepin- 1-carboxamide |
| 01/24/2001 | EP1070078A2 Form vi 5,6-dichloro-2-(isopropylamino)-1-beta-l-ribofuranosyl)-1h-benzimidazole |
| 01/24/2001 | EP1070077A1 15-membered lactams ketolides with antibacterial activity |
| 01/24/2001 | EP1070069A1 Bicyclic hydroxamic acid derivatives |
| 01/24/2001 | EP1070068A1 Granulatimide derivatives for use in cancer treatment |
| 01/24/2001 | EP1070067A1 Cytotoxic alkaloid derivatives including asmarine a and b isolated from a sponge |
| 01/24/2001 | EP1070066A1 SUBSTITUTED 1,2,4-TRIAZOLO 3,4-a]PYRIDAZINE |
| 01/24/2001 | EP1070065A1 Azabicyclic 5ht1 receptor ligands |
| 01/24/2001 | EP1070064A1 Antagonists of gonadotropin releasing hormone |
| 01/24/2001 | EP1070063A1 Indol-3-yl-cyclohexyl amine derivatives for the treatment of depression (5-ht1 receptor antagonists) |
| 01/24/2001 | EP1070060A1 Heterocyclic glycyl beta-alanine derivatives as vitronectin antagonists |
| 01/24/2001 | EP1070059A1 Chromanone and thiochromanone derivatives |
| 01/24/2001 | EP1070058A1 (4-arylsulfonylamino)-tetrahydropyran-4-carboxylic acid hydroxamides |
| 01/24/2001 | EP1070057A1 7-hexanoyltaxol and methods for preparing the same |
| 01/24/2001 | EP1070056A1 Phthalazinone pde iii/iv inhibitors |
| 01/24/2001 | EP1070051A1 Process for the production of r-(+)-6- carboxamido- 3-n- methylamino- 1,2,3,4- tetrahydrocarbazole |
| 01/24/2001 | EP1070050A1 N-aryloxyethyl-indoly-alkylamines for the treatment of depression (5-ht1a receptor active agents) |
| 01/24/2001 | EP1070049A1 Benzamide and sulfonamide substituted aminoguanidines and alkoxyguanidines as protease inhibitors |
| 01/24/2001 | EP1070048A1 Calcilytic compounds |
| 01/24/2001 | EP1070047A2 Lipids |
| 01/24/2001 | EP1070046A1 Propanolamine derivatives |
| 01/24/2001 | EP1070037A1 Anti-inflammatory, antibacterial benzyl phenol agents |
| 01/24/2001 | EP1069915A2 Hydroxylation activated drug release |
| 01/24/2001 | EP1069909A2 Conjugate vaccines for the prevention of dental caries |
| 01/24/2001 | EP1069906A1 Conjugates useful in the treatment of prostrate cancer |
| 01/24/2001 | EP1069904A1 Novel therapeutic agents interfering in neutrophil migration |
| 01/24/2001 | EP1069903A1 Novel nucleoside analogs and uses in treating disease |
| 01/24/2001 | EP1069902A1 Use of phospholipids for the manufacture of a medicament for the prevention of adhesions |
| 01/24/2001 | EP1069901A1 Calcilytic compounds and method of use |
| 01/24/2001 | EP1069900A1 Use of reboxetine for the treatment of neuropsychiatric disorders |
| 01/24/2001 | EP1069899A1 Treatment of panic attacks |
| 01/24/2001 | EP1069898A1 Topical antiseptic compositions and methods |
| 01/24/2001 | EP1069897A1 Methods for inhibiting mrp1 |
| 01/24/2001 | EP1069896A1 Carvedilol-galenics |
| 01/24/2001 | EP1069895A2 Compositions containing lysophosphatidic acids which inhibit apoptosis and uses thereof |
| 01/24/2001 | EP1069894A1 Spisulosine compounds having antitumour activity |
| 01/24/2001 | EP1069893A2 Use of dexmedetomidine for icu sedation |
| 01/24/2001 | EP1069892A1 Therapeutic system which can be moisture-activated |
| 01/24/2001 | EP1069887A1 Aerosol composition |
| 01/24/2001 | EP1069885A1 Ophthalmic solution comprising glycogen |
| 01/24/2001 | EP1069884A1 Cosmetic or pharmaceutical agents containing ribonucleic or desoxyribonucleic acids |
| 01/24/2001 | EP1069883A1 Cholesterol sulfate compositions for enhancement of stratum corneum function |
| 01/24/2001 | EP0971585A4 Method of inhibiting cancer growth |
| 01/24/2001 | EP0931080A4 Amorphous paroxetine composition |
| 01/24/2001 | EP0904392B1 Retroviral vectors |
| 01/24/2001 | EP0868192A4 Fast drying, film forming iodine release solution |
| 01/24/2001 | EP0821673B1 New form of (e)-3- 6- (2,6-dichlorophenyl)-thio]methyl]-3-(2-phenylethoxy)-2-pyridinyl]-2-propenoic acid |
| 01/24/2001 | EP0788496B1 Apolipoprotein-b synthesis inhibitors |
| 01/24/2001 | EP0712389B1 Therapeutic compound - fatty acid conjugates |
| 01/24/2001 | EP0706523B1 Substituted arylthioalkylthiopyridines |
| 01/24/2001 | EP0694039B1 1,5-benzodiazepine derivatives having cck antagonistic and or agonistic activity |
| 01/24/2001 | EP0689439B1 Use of triazine compounds in the preparation of a medicament for the treatment of memory and learning disorders |
| 01/24/2001 | EP0667349B1 Depression remedy |
| 01/24/2001 | EP0662830B1 (pi)-BOND AROMATIC VITAMIN CHELATES |
| 01/24/2001 | EP0610377B1 Tri-substituted tetrahydrofuran antifungals |
| 01/24/2001 | EP0573568B1 Use of nicotinic analogs for treatment of degenerative diseases of the nervous system |
| 01/24/2001 | CN1281468A Treatment with anti-ErbB2 antibodies |
| 01/24/2001 | CN1281459A Piperidine derivatives |
| 01/24/2001 | CN1281458A Purine compounds having PDE IV inhibitory activity and methods of synthesis |
| 01/24/2001 | CN1281455A 8-Azabicyclo [3,2,1] octane-3-methanamine derivatives as ligands of D2 and D3 dopamine and 5HT1A and 5HT2 serotonin receptors |
| 01/24/2001 | CN1281454A Hydrate of 5-[4-[2-(n-methyl-n-(2-pyridil) amino) ethyoxy] benzyl] thiazolidine-2,4-dione maleic acid salt |
| 01/24/2001 | CN1281453A 5-[4-[2-(n-methyl-n-(2-pyridil) amino) ethoxy] benzyl] thiazolidine-2,4-dione, maleic acid salt, hydrate as pharmaceutical |
| 01/24/2001 | CN1281451A Benzamine derivatives |
| 01/24/2001 | CN1281449A Crystalline antifungal polymorph |
| 01/24/2001 | CN1281448A Process for preparation of paroxetine hydrochloride |
| 01/24/2001 | CN1281447A (i(E))-3-[1-i(n)-butyl-5-[2-(-carboxyphenyl) methoxy-4-chlorophenyl]-1i(H)-pyrazol-4-yl]-2-[(5-methoxy-2,3-dihydrobenzofuran-6-yl) methyl]-prop-2-enoic acid monoargininyl salt |
| 01/24/2001 | CN1281444A Azulene hydroxamic acid derivatives as metalloprotein inhibitors |
| 01/24/2001 | CN1281443A Bicyclic compounds, process for their preparation and pharmaceutical composition containing them |
| 01/24/2001 | CN1281442A Novel compounds useful as neuro-protective agents |
| 01/24/2001 | CN1281441A Therapeutically active compounds based on indazole bioisostere replacement of catechol in PDE4 inhibitors |
| 01/24/2001 | CN1281439A 4-Hydroxyquinoline-3-carboxamides and hydrazides as antiviral agents |
| 01/24/2001 | CN1281438A Piperazine compounds and medical use thereof |
| 01/24/2001 | CN1281436A N-Benzyl-3-indenylacetamides derivatives for treating neoplasia |
| 01/24/2001 | CN1281434A Urethanes derived from azacycloalkanes, thio and dithio analogues, production and use thereof as 2,3 epoxysqualene lanesterol cyclase inhibitors |
| 01/24/2001 | CN1281433A Hydroxamic acid derivatives as matrix metalloprotease (MMP) inhibitors |
| 01/24/2001 | CN1281432A Alpha-aryl-N-alkylnitrones and pharmaceutical compositions containing same |
| 01/24/2001 | CN1281431A Urethanes, thio and dithio analogues, salts thereof, medicaments containing said compounds, use and method for production thereof |
| 01/24/2001 | CN1281430A N-alkanoylphenylalanine derivatives |
| 01/24/2001 | CN1281429A Novel aryloxy-alkyl-dialkylamines |
| 01/24/2001 | CN1281373A Pharmaceutical compositions containing cyclodextrins and taxoids |
| 01/24/2001 | CN1281363A Progestogen-antiprogestogen regimens |